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Abstract
Purpose While weight gain and obesity are the dominant factors, dietary sugar and specifically sugar-sweetened beverages 
(SSB) has been implicated in causing type 2 diabetes (T2DM). We assessed how much of the apparent effect of SSB is 
explained by adiposity, but not captured by adjustment for BMI, which is a poor index of body fat.
Methods We examined data from 5187 adults (mean age 50.8 years, SD = 16.4, 172 (3.3%) T2DM), from the Scottish Health 
Survey 2003 and 2008–2010 databases. Logistic regression was used to assess the association between SSB consumption 
and T2DM (non-insulin treated) and its attenuation (reduction in odds ratios, ORs), after entering published anthropometric 
indices of adiposity into the regression model, adjusted for age, sex, social class, education, smoking, alcohol consumption 
and physical activity.
Results Compared with low SSB categories (“less often/never”, once/week or 1–3 times/month), the OR without adiposity 
adjustment for having T2DM in high SSB consumers (2–3, 4–5, ≥ 6/day) was 2.56 (95% CI 1.12–5.83; p = 0.026). That 
OR was marginally changed by adjusting for BMI (+ 4.3%), WC (+ 5.5%) or total body fat (− 4.3%), but greatly attenuated 
by adjusting for estimated %body fat (− 23.4%). These indices had similar influences on the associations between SSB and 
T2DM combining known T2DM patients with unknown  HbA1c > 6.5%, > 48 mmol/mol.
Conclusions Associations between SSB and T2DM are attenuated more markedly by adjustment with estimated %body 
fat than with BMI, indicating an adiposity effect not captured using BMI. Future research should employ best available 
estimates of adiposity.
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Introduction
The global prevalence of adult type 2 diabetes mellitus 
(T2DM) has nearly doubled from 4.7% in 1980 to 8.5% 
(422 million cases) in 2014, coinciding with trends in obe-
sity and overweight [1]. The burden of diabetes was found 
strongly attributable to overweight and physical inactivity 
by comparative risk assessment [2]. Furthermore, T2DM 
has now been proven to be preventable, with body weight 
control being the dominant factor, with lesser influences 
from physical activity, and more minor dietary factors such 
as reducing saturated fats, increasing fruit and vegetables, 
magnesium and dietary fibre [3–5].
For historical reasons and through limited understand-
ing of nutrition, a direct association has been assumed by 
many between raised ‘blood sugar’ and dietary sugar [5]. 
Ecological data support an association (not necessarily 
causal) between average sugar use and diabetes prevalence 
[6], but the relationship is potentially confounded by more 
frequent overweight and obesity in countries with more dia-
betes: attempting to correct this for average BMI will not 
remove the influence of fatness, as BMI correlates rather 
weakly with body fat [7]. Obtaining reliable quantitative 
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data on total dietary intake of individuals, from which to 
estimate sugar consumption, is not possible because over-
weight and obese individuals (who must have relatively high 
energy consumptions to remain overweight) are well known 
to under-report total food consumptions systematically [8, 
9]. However, reported consumptions of specific foods and 
drinks, such as sweetened beverages, are considered more 
reliable because their consumption patterns are more stable 
[10]. Sugar-sweetened beverages (SSB) have come under 
particular scrutiny in relation to diabetes because they pro-
voke a high blood glucose peak, and because calories in 
liquid have a weaker effect on satiety than in solid form [11].
A large recent study by Imamura et al. found BMI mar-
ginally attenuates the association between SSB consumption 
and T2DM [12], but neither this nor any previous popula-
tion-based studies have investigated measurements or esti-
mates of body fat itself as a confounding factor which might 
be responsible for this association. The present study was 
conducted to establish the extent to which the association 
between SSB intake and T2DM is attenuated by commonly 
used indices of adiposity including BMI, waist circum-
ference (WC), and estimates of total adipose tissue mass 
(TATM) and percent body fat (BF%).
Methods
Data source
This study combined available datasets of Scottish Health 
Surveys 2003, 2008, 2009 and 2010 [13] and used ‘complete 
cases’ of individuals for whom the necessary data were col-
lected to be able to compare all the adiposity indices. The 
whole survey program comprised a household survey and an 
individual survey, among a total of 38,863 free-living par-
ticipants elected from electoral registers to be nationally rep-
resentative. Those under 18 years old at last birthday, preg-
nant, and on insulin treatment (potentially cases of T1DM, 
or T2DM with secondary weight gain) were all excluded 
(n = 10,734) leaving 28,136 participants. For 6358 of these 
participants after exclusions, nurse-led interviews were con-
ducted using standard questionnaires to collect information 
on the participants’ sociodemographic characteristics and 
lifestyle variables, providing measured anthropometric data 
and blood samples for glycated haemoglobin  (HbA1c).
Physical activity level was assessed from reported num-
ber of days per week with any physical activities lasting ≥ 30 
or 10–29 min of exercise sessions and categorised into 
groups of none (physical inactivity), active < 1 day/week, 
1 or 2 days/week, 3 or 4 days/week and ≥ 5 days/week. 
Smoking status was defined as never smoker, used to smoke 
occasionally, used to smoke regularly and current smoker. 
Alcohol consumption was defined according to frequency 
of drinking: never-drinkers, drinking once or twice/year, 
once every couple of months, once or twice a month, once 
or twice a week, 3 or 4 times/week, 5 or 6 times/week and 
almost every day. Education level attainment was grouped 
into other school level or no qualifications, standard grade 
or equivalent, higher grade or equivalent, higher national 
certificate/diploma or equivalent and degree or higher. Soci-
oeconomic classes were determined from occupation and 
classified as unskilled manual, semi-skilled manual, skilled 
manual, skilled non-manual, managerial technical and pro-
fessional [13].
Sugar‑sweetened beverage intakes
During interviews, SSB consumption frequency (without 
volume) of soft drinks was recorded as “less often or never”, 
1–3 times per month, 1, 2–4, 5–6 times per week, 1, 2–3, 
4–5, ≥ 6, times per day, which were categorised from 1 to 9 
respectively for analysis.
Diabetes cases and  HbA1c
A previous diagnosis of diabetes by doctors was recorded. 
Among those without previous diagnosis of T2DM, those 
who had  HbA1c > 6.5% (48 mmol/mol) were added to the 
diagnosed T2DM group, in a second model.
Indices of adiposity
Four established indices of adiposity were assessed, to test 
their effect on the association between SSB and diabetes: 
BMI (kg/m2), WC (cm), total adipose tissue mass [TATM 
(kg)] calculated using equation derived by Al-Gindan et al. 
[14] which contains body weight and height for both sexes, 
plus WC for male and age for female, and BF% (% of body 
weight) using equation derived by Lean et al. [7] which con-
tains WC and age for both sexes.
Statistical analysis
From 28,136 participants we extracted 5187 cases with 
complete data for all variables of interest, (i.e. 22,949 with 
incomplete data or did not meet  inclusion criteria were 
excluded). There were no important differences between 
the extracted and excluded groups in gender distribution 
(M/F = 54.8/45.2 vs. 55.5/44.5%. p = 0.176), mean age 
(50.8 vs. 50.3 years, p = 0.093) or BMI (27.5 vs. 27.8 kg/
m2, p < 0.05). Predictor variables were categorised into three 
categories: For SSB, category 1–3 indicates lowest drink-
ing frequency of “less often or never”, 1–3 times/month 
or once/week; category 4–6 indicates drinking frequency 
of 2–4 or 5–6 times/week or once/day, and category 7–9 
indicates highest drinking frequency of 2–3, 4–5 or ≥ 6/
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day. Chi-square test was used to assess differences in T2DM 
prevalence across different categories of SSB and adipos-
ity and logistic regression to assess the association between 
SSB and previously diagnosed T2DM. Indices of adipos-
ity were individually entered into the logistic regression 
model to examine the degree in which this association was 
affected, indicated by changes in odds ratios (ORs). Analysis 
was repeated with the addition of cases without previous 
diagnosis of T2DM but with  HbA1c > 6.5% (48 mmol/mol). 
Data were adjusted for age, sex, social class, smoking sta-
tus, alcohol consumption, education attainment and physical 
activity level. Analyses were performed using SPSS V.22.0 
(SPSS Inc, Chicago, IL, USA). Statistical significance was 
accepted when p < 0.05.
The influences of adiposity on the association between 
SSB and T2DM were expressed as percentage reduction 
from 100%, by dividing the “difference between OR after 
adjustment minus OR before adjustment for adiposity” over 
“OR before adjustment for adiposity”.
Results
Men and women had similar mean age (51.1 and 50.5 years), 
BMI (27.6 and 27.4 kg/m2) and  HbA1c 5.32% (34.7 mmol/
mol) and 5.30% (34.4 mmol/mol). Men had larger WC than 
women (by 10 cm, p < 0.001) while women had greater 
amount of TATM (4.7 kg, p < 0.001) and BF% (11.6% of 
body weight, p < 0.001) than men (Table 1).
The prevalence of T2DM was 1.8% in men who had the 
lowest intake of SSB (“less often or never”, once/week or 
1–3 times/month), 1.3% in men who consumed between 2 
and 4 or 5–6 times/week and once/day, and 4.9% in men 
who had the highest intake of SSB (2–3, 4–5, ≥ 6 per day) 
(χ2 = 19.0, p < 0.001); the respective values of T2DM 
prevalence across SSB categories for women were 1.7, 
2.7 and 3.3% (χ2 = 2.8, p < 0.242). A significantly greater 
prevalence of T2DM was observed for those in higher ter-
tiles of all adiposity measures in both sexes (Table 2).
We found similar influences by these indices on the 
association between SSB and known T2DM patients 
combined with unknown T2DM who had  HbA1c > 6.5% 
(48 mmol/mol).
Table 3 shows that compared with those with the low-
est SSB intake (“less often or never”, once/week or 1–3 
times/month), OR for having T2DM in those with highest 
SSB intake (2–3, 4–5, ≥ 6/day), without adiposity adjust-
ment, was 2.56 (95% CI 1.12–5.83, p = 0.026). That OR 
was minimally changed by adjustment for BMI (+ 4.3%), 
WC (+ 5.5%) or total body fat (− 4.3%), while greatly 
attenuated by %body fat (− 23.4%) (Fig. 1). There was a 
similar association between SSB and T2DM in the larger 
combined model, including known (diagnosed) (n = 172) 
with those previously undiagnosed but with  HbA1c > 6.5% 
(48 mmol/mol) (n = 230): OR = 1.93 (95%CI: 1.01–3.69, 
p = 0.046) (Table 4) and similar magnitude of changes in 
this association by indices of adiposity (Fig. 1).
We observed that BF% had stronger associations than 
BMI with SSB (χ2 = 27.0, p < 0.001 vs. 21.2; p < 0.001) 
and with T2DM (χ2 = 130.2; p < 0.001 vs. 102.5; 
p < 0.001). Among T2DM, we found that, compared with 
patients with  HbA1c < 6.5% (48 mmol/mol), more of those 
with  HbA1c > 6.5% (48 mmol/mol) had figures in the high-
est tertile of WC (26.6 vs. 73.4%, χ2 = 8.2, p = 0.016) and 
BF% (25.6 vs. 74.4%, χ2 = 12.3, p = 0.002) but did not have 
significantly higher BMI (p = 0.253), TATM (p = 0.171) or 
SSB intake (p = 0.124).
We examined relationships between SSBs and  HbA1c in 
people who were not diabetic: the associations were trivial 
though statistically significant, and no effect was evident 
from adjustment for BMI, WC or BF%. We also examined 
separately those who were not previously diagnosed with 
diabetes but had  HbA1c levels > 6.5% (> 48 mmol/mol). 
Table 1  Subject characteristics 
including age, anthropometry, 
estimated skeletal and fat 
masses and percentages and 
 HbA1c
a HbA1c in 1823 men and 2086 women who were not previously diagnosed with T2DM
Men (n = 2347) Women (n = 2840) Independent t test for group differences 
(male values minus female values)
Mean SD Mean SD Mean 95% CI p
Age (years) 51.1 16.6 50.5 16.3 0.6 − 0.3, 1.5 0.228
Weight (kg) 83.6 14.5 70.6 14.3 13.0 12.2, 13.7 < 0.001
Height (cm) 174.0 7.1 160.6 6.7 13.4 13.0, 13.8 < 0.001
BMI (kg/m2) 27.6 4.5 27.4 5.4 0.2 − 0.1, 0.5 0.139
Waist (cm) 97.1 11.9 87.1 13.0 10.0 9.3, 10.7 < 0.001
TATM (kg) 24.6 8.1 29.3 11.0 − 4.7 − 5.2, − 4.1 < 0.001
BF% (% body weight) 28.4 7.4 40.0 7.4 − 11.6 − 12.0, − 11.2 < 0.001
HbA1c (%)a 5.32 0.49 5.30 0.47 0.02 − 0.01, 0.05 0.153
HbA1c (mmol/mol)a 34.7 5.3 34.4 5.2 0.2 − 0.1, 0.6 0.153
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Numbers with complete data in this interesting group were 
too small for separate analysis.
Discussion
The present study shows that the weak association of SSB 
and T2DM, found fairly consistently in epidemiological 
studies, was changed marginally by BMI and WC but more 
markedly by better indices of body fat. Body fatness is, 
therefore important confounding factor, reflecting the com-
plex interactions of SSB and caloric intake in the develop-
ment of obesity and T2DM.
SSB consumption has previously been related to high 
BMI [15], particularly among adults aged under 45 years 
[16], which is supported by our results. Imamura et al. [12] 
conducted a meta-analysis of 17 studies comprising 38,253 
cases with T2DM studied over 10,126,754 person years, 
mostly using food frequency questionnaires for dietary 
assessment. The positive association between SSB consump-
tion and risk of T2DM was attenuated by BMI, indicated 
Table 2  Distribution of SSB, indices of adiposity and lifestyle factors in men and in women in patients with diagnosed T2DM and those with no 
previous T2DM diagnosis but with  HbA1c > 6.5% (48 mmol/mol)
a For SSB, category 1–3 indicates lowest drinking frequency of “less often or never”, 1–3 times per month or 1 time per week; category 4–6 indi-
cates drinking frequency of 2–4, 5–6 times per week or 1 time per day, and category 7–9 indicates highest drinking frequency of 2–3, 4–5 or ≥ 6 
per day. For indices of adiposity, three sex-specific tertiles were created
Men Women
Diagnosed T2DM 
(n = 85 cases and 
2262 non-cases)
Diagnosed 
T2DM + no 
previous T2DM 
diagnosis with 
 HbA1c > 6.5% 
(48 mmol/mol) 
(n = 114 cases and 
2233 non-cases)
Diagnosed T2DM 
(n = 87 cases and 
2753 non-cases)
Diagnosed 
T2DM + no previous 
T2DM diagnosis 
with  HbA1c > 6.5% 
(48 mmol/mol) 
(n = 116 cases and 
2724 non-cases)
Categories of SSB intake and indices of  adipositya % χ2 p % χ2 p % χ2 p % χ2 p
SSB category 1–3 1.8 19.0 < 0.001 3.2 12.8 0.002 1.1 2.8 0.242 1.7 2.9 0.236
SSB category 4–6 1.3 2.7 2.7 4.6
SSB category 7–9 4.9 6.1 3.3 4.2
BMI lowest tertile (M < 25.48, F < 24.47 kg/m2) 1.3 40.3 < 0.001 1.9 46.8 < 0.001 0.7 63.4 < 0.001 1.2 81.0 < 0.001
BMI middle tertile (M ≥ 25.48-, F ≥ 24.47 kg/m2) 2.6 3.6 1.8 2.3
BMI highest tertile (M ≥ 29.00, F ≥ 28.88 kg/m2) 7.0 9.0 6.7 8.8
WC lowest tertile (M < 91.25, F < 80.55 cm) 1.4 42.6 < 0.001 1.9 47.1 0.5 53.5 < 0.001 0.7 80.9 < 0.001
WC middle tertile (M ≥ 91.25, F ≥ 80.55 cm) 2.3 3.6 2.4 2.8
WC highest tertile (M ≥ 101.70, F ≥ 91.15 cm) 7.1 9.0 6.2 8.6
TATM lowest tertile (M < 26.52, F < 37.01 kg) 0.7 48.9 < 0.001 1.3 62.4 < 0.001 1.3 40.3 < 0.001 1.3 43.4 < 0.001
TATM middle tertile (M ≥ 26.52, F ≥ 37.01 kg) 2.3 2.9 2.6 2.4
TATM highest tertile (M ≥ 31.44, F ≥ 43 kg) 6.1 8.1 7.0 7.2
BF% lowest tertile (M < 24.93, F < 36.37% of weight) 1.0 50.6 < 0.001 1.5 56.0 0.2 81.8 < 0.001 0.3 119.6 < 0.001
BF% middle tertile (M ≥ 24.93-, F ≥ 36.37- % of weight) 2.4 3.4 1.9 2.2
BF% highest tertile (M ≥ 31.36, F ≥ 43.14% of weight) 7.4 9.6 7.1 9.7
Fig. 1  Attenuation of the association between SSB and T2DM (solid 
bars) and between SSB and previously diagnosed T2DM + no previ-
ous T2DM diagnosis with  HbA1c > 6.5% (48 mmol/mol) (open bars) 
by different indices of adiposity indicated by the relative reduction of 
ORs
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by a small reduction in relative risk from 1.18 (95% CI 
1.09–1.28) to 1.13 (95% CI 1.06–1.21). Using our calcula-
tion method, this reduction represents 4.2% attenuation in 
the association between SSB and T2DM. Our present study 
found a little change after adjustment by BMI, WC (+ 4–6%) 
or estimated TATM (− 4%), but substantially greater attenu-
ation by estimated BF% (-23%).
BMI is frequently used as an indicator of adiposity and 
routinely recorded in large epidemiological studies [17]. 
However, BMI has only weak correlation with body fat, 
because BMI does not distinguish between body fat and 
muscle mass [18]. Thus, BMI explains only 60–70% of vari-
ance in percent body fat measured by reference techniques 
such as underwater weighing [7]. The present study found 
that BMI explained 72.4% of variance of BF% as estimated 
by previous published equations [7], therefore, about 30% of 
residual variance from body fat remains to confound analy-
ses. In slimmer, more muscular and younger populations, the 
relationship between BMI and body fat may be even weaker. 
WC, now also available in most health surveys, has a slightly 
better correlation with total body fat, as well as indicating 
body fat distribution [19]. We found both BMI and WC had 
minimal effect on the association between SSB and T2DM. 
We also examined BF%, estimated by equations based again 
on simple measurements made in most health surveys [7, 
14]. This provided the greatest attenuation, but these equa-
tions still only explain some 80% of variance in body fat, so 
the weakened remaining association between SSB consump-
tion and T2DM includes substantial residual variance from 
body fat. The new estimates of body fatness using validated 
equations are preferable to BMI for other purposes.
The association of SSBs with health problems such as 
T2DM may be better explained by the modern patterns of 
eating, and snacking, which are characterised by high con-
sumption of SSBs, than by the sugar itself. The current study 
is in line with this view. For decades, some have asserted 
fervently that sugar causes obesity and T2DM while others 
blamed artificial sweeteners for obesity and cancers with-
out solid scientific evidence. During human evolution, the 
sweetest food we ever met—except honey—was human milk 
until the nineteenth century when unnaturally sweet drinks 
and sugary-fatty snacks were invented which had become 
abundant by the twentieth century. This sudden availabil-
ity led to adverse effects, just as experimental animals fed 
“cafeteria diets” develop obesity and diabetes. Although 
glucose is an essential nutrient necessary for the function of 
every cell in our bodies, it is technically not essential in our 
diets, being readily generated from other foods. There are 
Table 3  Logistic regression 
analysis to assess relative 
changes in the association of 
SBB and previously diagnosed 
T2DM by indices of adiposity
All models were adjusted for age, sex, social class, education attainment, smoking status, alcohol consump-
tion and physical activity level
a For SSB, category 1–3 indicates lowest = “less often/never”, 1–3 times/month or once/week; category 
4–6 indicates intermediate = 2–4 or 5–6 times/week or once/day, and category 7–9 indicates highest 
intake = 2–3, 4–5 or ≥ 6/day. Indices of adiposity and age were entered as continuous variables
b Relative changes in OR by indices of adiposity were calculated by dividing (the difference between 
OR after adiposity adjustment and OR before adiposity adjustment) over OR before adiposity adjust-
ment × 100%, e.g. to calculate changes by BF%: [(1.96–2.56)/2.56] × 100% = − 23.4%
Predictor  variablesa Diagnosed T2DM (n = 172 cases and 5015 non-cases)
OR 95% CI p Relative changes in OR 
by indices of  adiposityb 
(%)
SSB 1–3 (referent) 1 – – –
SSB 4–6 1.19 0.48–2.96 0.707 –
SSB 7–9 2.56 1.12–5.83 0.026 0
SSB 1–3 + BMI (referent) 1 – – –
SSB 4–6 + BMI 1.28 0.51–3.22 0.594 –
SSB 7–9 + BMI 2.67 1.16–6.14 0.021 + 4.3
SSB 1–3 + WC (referent) 1 – – –
SSB 4–6 + WC 1.21 0.48–3.04 0.683 –
SSB 7–9 + WC 2.70 1.07–5.60 0.020 + 5.5
SSB 1–3 + TATM (referent) 1 – – –
SSB 4–6 + TATM 1.25 0.50–3.12 0.639 –
SSB 7–9 + TATM 2.45 1.07–5.63 0.035 − 4.3
SSB 1–3 + BF% (referent) 1 – – –
SSB 4–6 + BF% 1.07 0.43–2.68 0.885 –
SSB 7–9 + BF% 1.96 0.85–4.49 0.114 − 23.4
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health benefits from sugar-containing fruits and vegetables, 
but sugar added during manufacturing confers no physical 
benefits. Added sugars have presented a reasonable target 
for taxation to raise revenue since the 1930s [20, 21], now 
proposed explicitly against obesity [22].
The term “added sugars” can be confusing. They include 
“refined sugars” (either natural, from cane, or synthetic, 
made from grain or beet crops), but sweetness is also added 
to foods from natural sugar, from raisins, apple juice, 
honey, etc. All are biologically identical once inside the 
gut. Sucrose (table sugar) is a disaccharide comprising 
equal parts glucose and fructose. The fructose molecule is 
converted into glucose, our primary cellular nutrient. The 
evidence linking total, or added, sugar consumption with 
poor health is weak. Consumption of SSBs is more reliably 
estimated and so has a stronger evidence base for associa-
tions with poor health. SSBs contribute about 13% of total 
sugar intakes in the United Kingdom, up to 30% in children, 
but still below 5% of calories [23]. Reducing sugar in SSBs 
from 10 to 8% would affect about 0.4% of total calories, and 
under 1% even for the heaviest users. There are theoretical 
small benefits from sugar reduction, especially for those with 
very high intakes namely reducing blood pressure [24] and 
cardiovascular diseases [25]. If cutting down sugar intake 
can reduce weight gains by 2–3 kg [26], that would definitely 
help delay the onset of weight-related diseases like T2DM. 
There is no evidence, however, to support recommending 
a lower upper limit of sugar intake of a relatively generous 
10% of calories. Systematic reviews and meta-analyses find 
no weight-independent effect of sugar on diabetes develop-
ment [5, 26].
Two much-disputed bodies of evidence indicate that 
problems with obesity lie not with sugar or with sweeteners 
themselves, but with the modern eating patterns of snacking 
or grazing, which are marked by high consumption of both 
very sweet drinks and sugary/fatty snacks. First, a meta-
analysis of randomized controlled and prospective cohort 
studies found absolutely no effect on body weight when 
sugar is replaced with the same calories from other carbo-
hydrates [26]. Second, although evidence is conflicting [27], 
artificially sweetened drinks are also associated with weight 
gain [28]. It must be emphasised that this is only an associa-
tion, but experimental animals only gain weight when both 
drinking water and foods are sweetened, either with sugar or 
with artificial sweeteners [29]. Human epidemiology can be 
explained by essentially the same story: both SSBs and arti-
ficially sweetened “diet” versions cause tolerance to unnatu-
ral sweetness, which promotes weight gain, mainly by pro-
moting consumption of very sweet, energy-dense foods [5, 
29]. “Reverse causality” may contribute; people with weight 
Table 4  Logistic regression 
analysis to assess changes 
in the association of SBB 
and previously diagnosed 
T2DM + no previous T2DM 
diagnosis with  HbA1c > 6.5% 
(48 mmol/mol) by indices of 
adiposity
All models were adjusted for age, sex, social class, education attainment, smoking status, alcohol consump-
tion and physical activity level
a For SSB, category 1–3 indicates lowest = “less often/never”, 1–3 times/month or once/week; category 
4–6 indicates intermediate = 2–4 or 5–6 times/week or once/day, and category 7–9 indicates highest 
intake = 2–3, 4–5 or ≥ 6/day. Indices of adiposity and age were entered as continuous variables
b For calculations of attenuation, see footnote in Table 3
Predictor  variablesa Diagnosed T2DM + no previous T2DM diagnosis with  HbA1c > 6.5% 
(48 mmol/mol) (230 cases and 4957 non-cases)
OR 95% CI p Relative changes in OR 
by indices of  adiposityb 
(%)
SSB 1–3 (referent) 1 – – –
SSB 4–6 1.34 0.66–2.70 0.416 –
SSB 7–9 1.93 1.01–3.69 0.046 0
SSB 1–3 + BMI (referent) 1 – – –
SSB 4–6 + BMI 1.44 0.71–2.94 0.314 –
SSB 7–9 + BMI 2.00 1.04–3.87 0.038 + 3.6
SSB 1–3 + WC (referent) 1 – – –
SSB 4–6 + WC 1.36 0.67–2.77 0.398 –
SSB 7–9 + WC 2.02 1.05–3.90 0.035 + 4.7
SSB 1–3 + TATM (referent) 1 – – –
SSB 4–6 + TATM 1.40 0.69–2.85 0.354 –
SSB 7–9 + TATM 1.84 0.96–3.54 0.069 − 4.7
SSB 1–3 + BF% (referent) 1 – – –
SSB 4–6 + BF% 1.20 0.59–2.45 0.611 –
SSB 7–9 + BF% 1.46 0.76–2.82 0.258 − 24.4
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problems tend to choose diet drinks, but obese people prefer 
sweeter tastes and sweet, high-fat foods [30], and children 
who eat more fast foods prefer sweeter tastes [31].
The strengths of the present study lie in its relatively large 
homogeneous sample, with a wide range of SSB intakes 
and adiposity which enables us to reliably assess their rela-
tionships with T2DM, but the study has limitations. Causal 
links between SSB and T2DM cannot be established in this 
cross-sectional study, and there is some uncertainty the 
degree to which, under advice after diagnosis of T2DM, 
patients may have modified their ‘diabetogenic’ dietary 
habits [32, 33], particularly among ethnic minority groups 
[34]. In keeping with other published studies, some other 
factors were not available that could affect the association of 
SSB consumption and diabetes, such as dietary fat and fibre 
intake. The data available did not provide reliable quantita-
tive assessment of dietary components, and estimation of 
total energy intake was not possible with the data collected. 
However, SSB consumption frequency has been assumed 
by most researchers to relate indirectly with quantitative 
intake, and has consistently been shown to associate with 
diabetes. In our study, indices of adiposity were derived 
from validated anthropometric measurements, rather than 
measured directly. This is in common with all large epide-
miological studies, since these indices provide both practi-
cal and economical approach to assessment of adiposity; 
“direct” methods of measuring adiposity such as magnetic 
resonance imaging are too expensive and time consuming to 
both investigators and participants, and there is no evidence 
that other indirect methods such as bioimpedance are better 
than anthropometric estimates [19].
In conclusion, the association between SSB and T2DM 
is  changed by adiposity, most markedly by %body fat, indi-
cating the importance of adjustment for body fatness using 
validated equations such as those published by Lean et al. 
[7] and Al-Gindan et al. [14], rather than just BMI, in future 
research in this area.
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